Product
HD204
Aliases
Bevacizumab
2 clinical trials
3 indications
Indication
lung cancerIndication
Lung CancerIndication
Healthy Control ParticipantsClinical trial
A Randomised, Double-blind, Parallel Group, Equivalence, Multicentre Phase III Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Patients With Metastatic or Recurrent Non-squamous Non-small Cell Lung CancerStatus: Active (not recruiting), Estimated PCD: 2023-12-01
Clinical trial
A Phase I, Double-blind, Randomised, Single-dose, Parallel Group Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD204 and Bevacizumab (Avastin®) in Healthy Male SubjectsStatus: Completed, Estimated PCD: 2019-03-13